Click for the Mectizan Home page
About MDP   Onchocerciasis   Lymphatic Filariasis   MDP News   Mectizan Expert Committee (MEC) News
Lymphatic Filariasis References

1. Goa KL, McTavish D, Clissold SP. Ivermectin, a review of its antifilarial activity, pharmacokinetic properties, and clinical efficacy in onchocerciasis. Drugs 1991;42(4):640-658.
2. World Health Organization. Lymphatic filariasis: reasons for hope. Geneva: World Health Organization; 1997. Document No.: WHO/CTD/FIL/97.4 Rev.1.
3. World Health Organization. Onchocerciasis and its control, report of a WHO Expert Committee on Onchocerciasis Control. Geneva: World Health Organization; 1995. Technical Report Series No.: 852.
4. World Health Organization. Onchocerciasis Control Programme 1974-1994. Geneva: World Health Organization; 1995. Document No.: WHO/OCP/CTD/94.1.
5. Despommier DD, Gwadz RW, Hotez PJ, Knirsch CA. Parasitic Diseases. 4th ed. New York: Springer-Verlag; 2000. p. 138-142.
6. World Health Organization. Onchocerciasis - progress towards elimination in the Americas. Wkly Epidemiol Rec 1996;71(37): 277-279.
7. Thylefors B, Negrel A-D, Pararajasegaram R, Dadzie KY. Global data on blindness. Bulletin of the World Health Organization 1995;73(1): 115-121.
8. World Health Organization. Lymphatic filariasis. Wkly Epidemiol Rec 2001;76(20): 149-154.
9. Ottesen EA, Duke BOL, Karam M, Behbehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bulletin of the World Health Organization 1997;75(6): 491-503.
10. World Health Organization. Lymphatic Filariasis: the disease and its control, fifth report of the WHO Expert Committee on Filariasis. Geneva: World Health Organization; 1992. Technical Report Series No.: 821.
11. World Health Organization. Preparing and implementing a national plan to eliminate lymphatic filariasis (in countries where onchocerciasis is not co-endemic). Geneva: World Health Organization; 2000. Document No.: WHO/CDS/CPE/CEE/2000.15.
12. World Health Organization. Preparing and implementing a national plan to eliminate lymphatic filariasis (in countries where onchocerciasis is co-endemic). Geneva: World Health Organization; 2000. Document No.: WHO/CDS/CPE/CEE/2000.16.
13. Ogbuagu KF, Eneanya CI. A multi-centre study of the effect of Mectizan treatment on onchocercal skin disease: clinical findings. Ann Trop Med Parasitol 1998;92(Suppl 1): 139-145.

Introduction | Lifecycle | Distribution | Treatment Data | References
SIGN UP FOR OUR NEWSLETTER
Program
Information
History & Background

Onchocerciasis

Onchocerciasis treatments approved

Lymphatic Filariasis

Lymphatic Filariasis  treatments approved

Mass Treatment

Humanitarian Program / Special requests for Mectizan

How to Apply/
Review Process


Technical Requirements

Program Partners

MDP Brochures

NEW! Drug Management




Mectizan Donation
Program News
NEW! Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis

NEW! 2007 MDP Annual Highlights

NEW! Article on drug donations for NTDs in Nature

NEW!
"The Mectizan Donation Program—Highlights from 2005" published in the Filaria Journal (PDF)

"Towards the Elimination of Onchocerciasis" published in the Annals of Tropical Medicine and Parasitology (PDF)


Studies on the impact of MDP

MDP NEWSLETTER: current and archives

Mectizan Expert Committee News

News from the Mectizan Expert Committee / Albendazole Coordination Meetings

Recommendations for the treatment of onchocerciasis with Mectizan in areas co-endemic for onchocerciasis and loiasis

Merck Mectizan Award Winners

 
 
site map | advanced 
 Contact

Mectizan® Donation Program (MDP)
325 Swanton Way
Decatur, Georgia 30030
USA
P: +1 (404) 371-1460
F: +1 (404) 371-1138
Contact Us

To sign up for our newsletter please email mectizan@taskforce.org
Program Information   Onchocerciasis   Lymphatic Filariasis
MDP News   Mectizan Expert Committee News   Contact Us   Site Map
© 2008 Mectizan Donation Program. All Rights Reserved. Admin